ConductScience.org, home

Paper36036670

Effectiveness and safety of mexiletine in patients at risk for (recurrent) ventricular arrhythmias: a systematic review.

van der Ree MH and 9 others. Europace, 2022. Cited by 20 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Effectiveness and safety of mexiletine in patients at risk for (recurrent) ventricular arrhythmias: a systematic review. Papers, record 36036670. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36036670

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effectiveness and safety of mexiletine in patients at risk for (recurrent) ventricular arrhythmias: a systematic review.
PubMed
Journal
Europace
PubMed
Year
2022
PubMed
Publication types
Systematic Review, Journal Article
PubMed
Citations, by iCite
20
iCite
Relative citation ratio, by iCite
1.92
iCite
Revised in PubMed
2022-12-17
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1van der Ree MHMartijn Hhttps://orcid.org/0000-0002-2565-337X
2van Dussen LLaura
3Rosenberg NNoa
4Stolwijk NNina
5van den Berg SSibren
6van der Wel VVincent
7Jacobs BAWBart A W
8Wilde AAMArthur A Mhttps://orcid.org/0000-0002-0528-0852
9Hollak CEMCarla E Mhttps://orcid.org/0000-0003-0464-1078
10Postema PGPieter Ghttps://orcid.org/0000-0003-2863-9159

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
MexiletineMajor topic
Arrhythmias, CardiacMajor topic
Humans
Infant, Newborn
Infant
Child, Preschool
Child
Adolescent
Young Adult
Adult
Middle Aged
Aged
Aged, 80 and over
Ventricular Fibrillation
Electrocardiography
Heart Ventricles

Source PubMed

Download CSV of topics

References223

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
123580742Inhibition of late sodium current by mexiletine: a novel pharmotherapeutical approach in timothy syndrome.Circ Arrhythm Electrophysiol2013https://conductscience.org/library/papers/23580742PubMed
22929410Proarrhythmia related to a kinetic and dynamic interaction of mexiletine and theophylline.Am Heart J1989https://conductscience.org/library/papers/2929410PubMed
38800993Discrepant effects of mexiletine on cycle length of ventricular tachycardia and on the effective refractory period in the area of slow conduction.Heart1996https://conductscience.org/library/papers/8800993PubMed
4448936Mexiletine. Use in control of chronic drug-resistant ventricular arrhythmia.JAMA1979https://conductscience.org/library/papers/448936PubMed
569299Antiarrhythmic and haemodynamic effects of mexiletine.Postgrad Med J1977https://conductscience.org/library/papers/69299PubMed
62874902Mexiletine therapy in patients with chronic drug-resistant malignant ventricular arrhythmias. Clinical efficacy, safety, and side effects.Cleve Clin Q1986https://conductscience.org/library/papers/2874902PubMed
72738263Arrhythmogenic effects of antiarrhythmic drugs: a study of 506 patients treated for ventricular tachycardia or fibrillation.J Am Coll Cardiol1989https://conductscience.org/library/papers/2738263PubMed
82579918Lidocaine, mexiletine and propafenone in the treatment of arrhythmias complicating myocardial infarction. A case report.Int J Cardiol1985https://conductscience.org/library/papers/2579918PubMed
94124890Mexiletine (Kö 1173) in the management of ventricular dysrhythmias.Lancet1973https://conductscience.org/library/papers/4124890PubMed
109579816Idiopathic ventricular fibrillation: clinical, electrophysiologic characteristics and long-term outcomes.Int J Cardiol1998https://conductscience.org/library/papers/9579816PubMed
11352705Efficacy of oral mexiletine in the prevention of exercise-induced ventricular ectopic activity.Eur J Clin Pharmacol1978https://conductscience.org/library/papers/352705PubMed
1223583244Quinidine, a life-saving medication for Brugada syndrome, is inaccessible in many countries.J Am Coll Cardiol2013https://conductscience.org/library/papers/23583244PubMed
133983671Mexiletine therapy for ventricular tachycardia.South Med J1985https://conductscience.org/library/papers/3983671PubMed
1424102153Combination drug therapy for patients with intractable ventricular tachycardia associated with right ventricular cardiomyopathy.Pacing Clin Electrophysiol2014https://conductscience.org/library/papers/24102153PubMed
152199424Prophylactic use of mexiletine in the elderly with acute myocardial infarction.J Assoc Physicians India1990https://conductscience.org/library/papers/2199424PubMed
161281807Efficacy and safety of sotalol in patients with complex ventricular arrhythmias.Int J Cardiol1992https://conductscience.org/library/papers/1281807PubMed
1732435196Investigation of the Cellular Pharmacological Mechanism and Clinical Evidence of the Multi-Herbal Antiarrhythmic Chinese Medicine Xin Su Ning.Front Pharmacol2020https://conductscience.org/library/papers/32435196PubMed
187657847
Chronic effect of oral mexiletine administration on left ventricular contractility in patients with congestive heart failure: a study based on mitral regurgitant flow velocity measured by continuous-wave Doppler echocardiography.
J Clin Pharmacol1995https://conductscience.org/library/papers/7657847PubMed
197049204A trial of prophylactic mexiletine in home coronary care.Br Heart J1982https://conductscience.org/library/papers/7049204PubMed
2022360817Congenital long QT 3 in the pediatric population.Am J Cardiol2012https://conductscience.org/library/papers/22360817PubMed

See all 223 referencesDownload CSV of references

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.

PMIDTitleJournalYearIn PapersSource
42686760Innervated human cardiac muscle model reveals sympathetic drivers of KCNH2-associated arrhythmias.Nat Commun2026https://conductscience.org/library/papers/42686760PubMed
42358584Case Report: Nadolol-mexiletine combination therapy for refractory neonatal long QT syndrome: a case series beyond sodium channelopathies.Front Pediatr2026https://conductscience.org/library/papers/42358584PubMed
39458049Comparison of Oral Procainamide and Mexiletine Treatment of Recurrent and Refractory Ventricular Tachyarrhythmias.J Clin Med2024https://conductscience.org/library/papers/39458049PubMed
38927420Chronic Mexiletine Administration Increases Sodium Current in Non-Diseased Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.Biomedicines2024https://conductscience.org/library/papers/38927420PubMed
38867867The point on the treatment of arrhythmic storm.Eur Heart J Suppl2024https://conductscience.org/library/papers/38867867PubMed
38353682Relevance of mexiletine in the era of evolving antiarrhythmic therapy of ventricular arrhythmias.Clin Res Cardiol2024https://conductscience.org/library/papers/38353682PubMed
37917362Use of mexiletine in therapy-refractory recurrent ventricular tachycardia storm.Herzschrittmacherther Elektrophysiol2023https://conductscience.org/library/papers/37917362PubMed
37622577From gene-discovery to gene-tailored clinical management: 25 years of research in channelopathies and cardiomyopathies.Europace2023https://conductscience.org/library/papers/37622577PubMed
37369559Beneficial effects of chronic mexiletine treatment in a human model of SCN5A overlap syndrome.Europace2023https://conductscience.org/library/papers/37369559PubMed
37238395Antiarrhythmic Drug Dosing in Children-Review of the Literature.Children (Basel)2023https://conductscience.org/library/papers/37238395PubMed

Download CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CYP1A21544PubTator's text mininghttps://conductscience.org/library/genes/1544NCBI Gene
CYP2D61565PubTator's text mininghttps://conductscience.org/library/genes/1565NCBI Gene
CYP4F34051PubTator's text mininghttps://conductscience.org/library/genes/4051NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36036670

GET https://conductscience.org/api/papers/v1/36036670/references?page=2